Read the latest papers on Breast Cancer across BMC flagship journals.
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Joaquin Gavila et al.
Published in BMC Medicine 09 January 2019
VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX
Florian Bonin et al.
Published in BMC Biology 02 October 2018
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Elen Kristine Hoglander et al.
Published in Genome Medicine 29 November 2018
VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer
Andrew N. Holding et al.
Published in Genome Biology 13 May 2019
